VERO: Venus Concept Inc. Stock

by  •  • Comments Off on VERO: Venus Concept Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 4.24
Enterprise Value ($M) 74.36
Book Value ($M) -13.45
Book Value / Share -2.12
Price / Book -0.32
NCAV ($M) -40.66
NCAV / Share -6.40
Price / NCAV -0.10

Profitability (mra)
Return on Invested Capital (ROIC) -0.56
Return on Assets (ROA) -0.33
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.39
Current Ratio 2.13

Balance Sheet (mrq) ($M)
Current Assets 66.45
Assets 93.65
Liabilities 107.10
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 76.35
Operating Income -28.31
Net Income -37.25
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -12.86
Cash from Investing -0.12
Cash from Financing 6.80

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-01 13G Intracoastal Capital, Llc 4.99
02-29 13D/A Masters Capital Management Llc 21.23 -93.30
02-28 13D/A EW Healthcare Partners, L.P. 46.70 0.00
02-22 13D/A Madryn Asset Management, LP 20.00 -62.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 884 8,332 10.61
2024-04-30 2,532 3,188 79.42
2024-04-29 1,355 1,983 68.33
2024-04-26 8,314 4,888 170.09

(click for more detail)

Similar Companies
TTOO – T2 Biosystems, Inc. UFPT – UFP Technologies, Inc.
VANI – Vivani Medical, Inc. VVOS – Vivos Therapeutics, Inc.
XAIR – Beyond Air, Inc.


Financial data and stock pages provided by
Fintel.io